drugset / Trial / NCT07610304

Effect of Alpha Tocopherol and Psyllium on Lipid Levels in Dyslipidaemia Patients

NCT07610304

Phase 2 Completed 60 enrolled NUR International University
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to find out whether Vitamin E (Alpha tocopherol), taken alone or together with Psyllium husk (a type of dietary fibre), can improve blood fat levels in adults with dyslipidaemia (abnormal blood levels of two types of fat: cholesterol and triglycerides). The main questions this study aims to answer are: * Does Vitamin E (400 mg/day) alone help lower blood cholesterol and triglyceride levels? * Does combining Vitamin E (400 mg/day) with Psyllium husk (10 g/day) lead to better results compared to participants taking Vitamin E alone? Researchers will compare all three groups i.e. Group A taking Vitamin E alone, Group B taking Vitamin E and Psyllium husk and Group C receiving a placebo (a look alike supplement). The hypothesis of the study is that 'There is a noticeable difference between all the three study groups.' Participants will: * Take their assigned (specific to the concerned group under study) treatment daily for 60 days. * Visit study place every two weeks for follow-up. * Have blood tests done at the beginning and end of the study to check for changes in cholesterol and triglyceride levels.

Timeline

Start
2022-06-15
Primary completion
2022-08-15
Completion
2022-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Psyllium husk Unknown 10 g
Subject alpha-tocopherol Unknown 400 mg

Indications